Gwn Securities Inc.
Source: SEC Form 13F · as of Mar 2026Gwn Securities Inc. holds 18 biotech & pharma companies tracked by BioSniper, totaling $30.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$30.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 24,628 | $6.0M |
| CAHCardinal Health Inc. | 26,532 | $5.6M |
| LLYELI LILLY & Co | 5,105 | $4.7M |
| MCKMcKesson Corporation | 3,569 | $3.1M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 8,369 | $2.3M |
| ABBVAbbVie Inc. | 6,618 | $1.4M |
| GILDGILEAD SCIENCES, INC. | 10,088 | $1.4M |
| BMYBRISTOL MYERS SQUIBB CO | 15,543 | $943K |
| AMGNAMGEN INC | 2,498 | $879K |
| TGTXTG THERAPEUTICS, INC. | 24,725 | $821K |
| PMPhilip Morris International Inc | 4,602 | $761K |
| INNVINNOVUS PHARMACEUTICALS, INC. | 66,779 | $536K |
| NTLAIntellia Therapeutics, Inc. | 31,484 | $404K |
| PFEPFIZER INC | 13,566 | $381K |
| MRKMerck & Co., Inc. | 2,905 | $350K |
| GEHCGE HealthCare Technologies Inc. | 4,720 | $336K |
| NPCENeuropace Inc. | 22,644 | $298K |
| LFCRLIFECORE BIOMEDICAL, INC. DE | 13,975 | $52K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.